Cargando…

Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease

OBJECTIVE: Vitamin D and fibroblast growth factor-23 (FGF-23) are related with cardiovascular disorders. We have investigated the relationship of calcidiol (vitamin D metabolite) and FGF-23 plasma levels with the incidence of adverse outcomes in patients with coronary artery disease. METHODS: Prospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuñón, José, Cristóbal, Carmen, Tarín, Nieves, Aceña, Álvaro, González-Casaus, María Luisa, Huelmos, Ana, Alonso, Joaquín, Lorenzo, Óscar, González-Parra, Emilio, Mahíllo-Fernández, Ignacio, Pello, Ana María, Carda, Rocío, Farré, Jerónimo, Rodríguez-Artalejo, Fernando, López-Bescós, Lorenzo, Egido, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991663/
https://www.ncbi.nlm.nih.gov/pubmed/24748388
http://dx.doi.org/10.1371/journal.pone.0095402
_version_ 1782312479840272384
author Tuñón, José
Cristóbal, Carmen
Tarín, Nieves
Aceña, Álvaro
González-Casaus, María Luisa
Huelmos, Ana
Alonso, Joaquín
Lorenzo, Óscar
González-Parra, Emilio
Mahíllo-Fernández, Ignacio
Pello, Ana María
Carda, Rocío
Farré, Jerónimo
Rodríguez-Artalejo, Fernando
López-Bescós, Lorenzo
Egido, Jesús
author_facet Tuñón, José
Cristóbal, Carmen
Tarín, Nieves
Aceña, Álvaro
González-Casaus, María Luisa
Huelmos, Ana
Alonso, Joaquín
Lorenzo, Óscar
González-Parra, Emilio
Mahíllo-Fernández, Ignacio
Pello, Ana María
Carda, Rocío
Farré, Jerónimo
Rodríguez-Artalejo, Fernando
López-Bescós, Lorenzo
Egido, Jesús
author_sort Tuñón, José
collection PubMed
description OBJECTIVE: Vitamin D and fibroblast growth factor-23 (FGF-23) are related with cardiovascular disorders. We have investigated the relationship of calcidiol (vitamin D metabolite) and FGF-23 plasma levels with the incidence of adverse outcomes in patients with coronary artery disease. METHODS: Prospective follow-up study of 704 outpatients, attending the departments of Cardiology of four hospitals in Spain, 6–12 months after an acute coronary event. Baseline calcidiol, FGF-23, parathormone, and phosphate plasma levels were assessed. The outcome was the development of acute ischemic events (any acute coronary syndrome, stroke, or transient ischemic attack), heart failure, or death. Cox regression adjusted for the main confounders was performed. RESULTS: Calcidiol levels showed a moderate-severe decrease in 57.3% of cases. Parathormone, FGF-23, and phosphate levels were increased in 30.0%, 11.5% and 0.9% of patients, respectively. Only 22.4% of patients had glomerular filtration rate<60 ml/min1.73 m(2). After a mean follow-up was 2.15±0.99 years, 77 patients developed the outcome. Calcidiol (hazard ratio [HR] = 0.67; 95% confidence interval [CI] = 0.48–0.94; p = 0.021) and FGF-23 (HR = 1.13; 95% CI = 1.04–1.23; p = 0.005) plasma levels predicted independently the outcome. There was a significant interaction between calcidiol and FGF-23 levels (p = 0.025). When the population was divided according to FGF-23 levels, calcidiol still predicted the outcome independently in patients with FGF-23 levels higher than the median (HR = 0.50; 95% CI = 0.31–0.80; p = 0.003) but not in those with FGF-23 levels below this value (HR = 1.03; 95% CI = 0.62–1.71; p = 0.904). CONCLUSIONS: Abnormalities in mineral metabolism are frequent in patients with stable coronary artery disease. In this population, low calcidiol plasma levels predict an adverse prognosis in the presence of high FGF-23 levels.
format Online
Article
Text
id pubmed-3991663
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39916632014-04-21 Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease Tuñón, José Cristóbal, Carmen Tarín, Nieves Aceña, Álvaro González-Casaus, María Luisa Huelmos, Ana Alonso, Joaquín Lorenzo, Óscar González-Parra, Emilio Mahíllo-Fernández, Ignacio Pello, Ana María Carda, Rocío Farré, Jerónimo Rodríguez-Artalejo, Fernando López-Bescós, Lorenzo Egido, Jesús PLoS One Research Article OBJECTIVE: Vitamin D and fibroblast growth factor-23 (FGF-23) are related with cardiovascular disorders. We have investigated the relationship of calcidiol (vitamin D metabolite) and FGF-23 plasma levels with the incidence of adverse outcomes in patients with coronary artery disease. METHODS: Prospective follow-up study of 704 outpatients, attending the departments of Cardiology of four hospitals in Spain, 6–12 months after an acute coronary event. Baseline calcidiol, FGF-23, parathormone, and phosphate plasma levels were assessed. The outcome was the development of acute ischemic events (any acute coronary syndrome, stroke, or transient ischemic attack), heart failure, or death. Cox regression adjusted for the main confounders was performed. RESULTS: Calcidiol levels showed a moderate-severe decrease in 57.3% of cases. Parathormone, FGF-23, and phosphate levels were increased in 30.0%, 11.5% and 0.9% of patients, respectively. Only 22.4% of patients had glomerular filtration rate<60 ml/min1.73 m(2). After a mean follow-up was 2.15±0.99 years, 77 patients developed the outcome. Calcidiol (hazard ratio [HR] = 0.67; 95% confidence interval [CI] = 0.48–0.94; p = 0.021) and FGF-23 (HR = 1.13; 95% CI = 1.04–1.23; p = 0.005) plasma levels predicted independently the outcome. There was a significant interaction between calcidiol and FGF-23 levels (p = 0.025). When the population was divided according to FGF-23 levels, calcidiol still predicted the outcome independently in patients with FGF-23 levels higher than the median (HR = 0.50; 95% CI = 0.31–0.80; p = 0.003) but not in those with FGF-23 levels below this value (HR = 1.03; 95% CI = 0.62–1.71; p = 0.904). CONCLUSIONS: Abnormalities in mineral metabolism are frequent in patients with stable coronary artery disease. In this population, low calcidiol plasma levels predict an adverse prognosis in the presence of high FGF-23 levels. Public Library of Science 2014-04-18 /pmc/articles/PMC3991663/ /pubmed/24748388 http://dx.doi.org/10.1371/journal.pone.0095402 Text en © 2014 Tuñón et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Tuñón, José
Cristóbal, Carmen
Tarín, Nieves
Aceña, Álvaro
González-Casaus, María Luisa
Huelmos, Ana
Alonso, Joaquín
Lorenzo, Óscar
González-Parra, Emilio
Mahíllo-Fernández, Ignacio
Pello, Ana María
Carda, Rocío
Farré, Jerónimo
Rodríguez-Artalejo, Fernando
López-Bescós, Lorenzo
Egido, Jesús
Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease
title Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease
title_full Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease
title_fullStr Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease
title_full_unstemmed Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease
title_short Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease
title_sort coexistence of low vitamin d and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991663/
https://www.ncbi.nlm.nih.gov/pubmed/24748388
http://dx.doi.org/10.1371/journal.pone.0095402
work_keys_str_mv AT tunonjose coexistenceoflowvitamindandhighfibroblastgrowthfactor23plasmalevelspredictsanadverseoutcomeinpatientswithcoronaryarterydisease
AT cristobalcarmen coexistenceoflowvitamindandhighfibroblastgrowthfactor23plasmalevelspredictsanadverseoutcomeinpatientswithcoronaryarterydisease
AT tarinnieves coexistenceoflowvitamindandhighfibroblastgrowthfactor23plasmalevelspredictsanadverseoutcomeinpatientswithcoronaryarterydisease
AT acenaalvaro coexistenceoflowvitamindandhighfibroblastgrowthfactor23plasmalevelspredictsanadverseoutcomeinpatientswithcoronaryarterydisease
AT gonzalezcasausmarialuisa coexistenceoflowvitamindandhighfibroblastgrowthfactor23plasmalevelspredictsanadverseoutcomeinpatientswithcoronaryarterydisease
AT huelmosana coexistenceoflowvitamindandhighfibroblastgrowthfactor23plasmalevelspredictsanadverseoutcomeinpatientswithcoronaryarterydisease
AT alonsojoaquin coexistenceoflowvitamindandhighfibroblastgrowthfactor23plasmalevelspredictsanadverseoutcomeinpatientswithcoronaryarterydisease
AT lorenzooscar coexistenceoflowvitamindandhighfibroblastgrowthfactor23plasmalevelspredictsanadverseoutcomeinpatientswithcoronaryarterydisease
AT gonzalezparraemilio coexistenceoflowvitamindandhighfibroblastgrowthfactor23plasmalevelspredictsanadverseoutcomeinpatientswithcoronaryarterydisease
AT mahillofernandezignacio coexistenceoflowvitamindandhighfibroblastgrowthfactor23plasmalevelspredictsanadverseoutcomeinpatientswithcoronaryarterydisease
AT pelloanamaria coexistenceoflowvitamindandhighfibroblastgrowthfactor23plasmalevelspredictsanadverseoutcomeinpatientswithcoronaryarterydisease
AT cardarocio coexistenceoflowvitamindandhighfibroblastgrowthfactor23plasmalevelspredictsanadverseoutcomeinpatientswithcoronaryarterydisease
AT farrejeronimo coexistenceoflowvitamindandhighfibroblastgrowthfactor23plasmalevelspredictsanadverseoutcomeinpatientswithcoronaryarterydisease
AT rodriguezartalejofernando coexistenceoflowvitamindandhighfibroblastgrowthfactor23plasmalevelspredictsanadverseoutcomeinpatientswithcoronaryarterydisease
AT lopezbescoslorenzo coexistenceoflowvitamindandhighfibroblastgrowthfactor23plasmalevelspredictsanadverseoutcomeinpatientswithcoronaryarterydisease
AT egidojesus coexistenceoflowvitamindandhighfibroblastgrowthfactor23plasmalevelspredictsanadverseoutcomeinpatientswithcoronaryarterydisease